Trial Profile

A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Efficacy and Safety of Ustekinumab in the Treatment of Korean and Taiwanese Subjects With Moderate to Severe Plaque-type Psoriasis

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 20 Oct 2020

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

23 Sep 2020 Results of pooled analysis of data pooled from 4 studies ( CADMUS, CADMUS-JR, LOTUS and PEARL) extrapolating pharmacodynamic effects of Ustekinumab from Adults to Pediatrics, presented at the 2020 American College of Clinical Pharmacology Annual Meeting
31 Aug 2020 Results of pooled analysis (of data from CADMUS, CADMUS JR, LOTUS and PEARL) extrapolating pharmacodynamic effects from adults to pediatrics published in the Clinical Pharmacology and Therapeutics
01 Sep 2011 Results published in the Journal of Dermatological Science.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com